Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear hormone receptor subfamily 2 group E member 3 (NR2E3), also known as photoreceptor cell-specific nuclear receptor (PNR), is a photoreceptor-specific orphan nuclear hormone receptor that plays a critical role in the development and maintenance of retinal photoreceptors, particularly rods. It acts as both an activator and repressor in gene regulation. Mutations in NR2E3 are associated with several inherited retinal diseases, including Enhanced S-cone syndrome (ESCS), Goldmann-Favre syndrome, Retinitis pigmentosa, and Clumped pigmentary retinal degeneration (CPRD).
NR2E3 acts as both an activator and repressor in gene regulation, binding to promoter regions of rod and cone genes. It self-dimerizes into a default repressor state. Synthetic modulators can act as agonists, reverse agonists, or allosteric modulators.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor subfamily 2 group E member 3 (NR2E3).